Yusuke Nakamura to Enhancer of Zeste Homolog 2 Protein
This is a "connection" page, showing publications Yusuke Nakamura has written about Enhancer of Zeste Homolog 2 Protein.
Connection Strength
0.087
-
Clinicopathologic significance of protein lysine methyltransferases in cancer. Clin Epigenetics. 2020 10 13; 12(1):146.
Score: 0.041
-
The oncogenic polycomb histone methyltransferase EZH2 methylates lysine 120 on histone H2B and competes ubiquitination. Neoplasia. 2013 Nov; 15(11):1251-61.
Score: 0.025
-
Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Cancer Sci. 2011 Jul; 102(7):1298-305.
Score: 0.021